Evaluation of Treatment Response to Ipilimumab in Patients with metastatic malignant Melanoma

被引：0
|
作者：
Rudolph, B. M. [1 ]
Mueller-Brenne, T. [1 ]
Groffik, A. [1 ]
Wilden, S. [1 ]
Grabbe, S. [1 ]
Loquai, C. [1 ]
机构：
[1] Univ Med Mainz, Hautklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：930 / 931
页数：2
相关论文
共 50 条
  • [1] Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient
    Addeo, Alfredo
    Rinaldi, Ciro Roberto
    CASE REPORTS IN ONCOLOGY, 2013, 6 (02): : 285 - 288
  • [2] Metastatic malignant melanoma. Successfull treatment with ipilimumab
    Jansen, T.
    Bruch-Gerharz, D.
    Reifenberger, J.
    Schulte, K. W.
    HAUTARZT, 2013, 64 (04): : 228 - +
  • [3] Evaluation of the Long-Term Survival after Treatment with Ipilimumab or Vemurafenib in Patients with Metastatic Malignant Melanoma
    Rudolph, B. M.
    Groffik, A.
    Faidt, D.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 2 - 3
  • [4] Partial Remission of metastatic Malignant melanoma after Treatment with Ipilimumab
    Liakou, Aikaterini I.
    Trebing, Dietrich
    Zouboulis, Christos C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 9 - 9
  • [5] A response to the ipilimumab treatment of a patient with a diagnosis of metastatic melanoma
    Pekala, Anika
    Ulanska, Malgorzata
    Blasinska-Morawiec, Maria
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 : H1 - H6
  • [6] Ipilimumab in metastatic malignant melanoma: The Irish experience
    Donnellan, Paul P.
    Bambury, Richard
    Battley, Jodie E.
    Power, Derek Gerard
    O'Byrne, Kenneth John
    Crown, John
    Breathnach, Oscar S.
    Teo, MinYuen
    Jamaluddin, Muhammad Faisal
    Boychak, Oleksandr Volodymyrovych
    Lyons, Tomas
    Greene, John
    Jayaram, Anuradha
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Repeated Treatment Response of metastatic malignant Melanoma to Ipilimumab in a Patient with chronic lymphatic Leukaemie - a Case Report
    Mueller-Brenne, T.
    Hurlbeck, S.
    Wilden, S.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 33 - 33
  • [8] Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
    Bjoern, Jon
    Nitschke, Nikolaj Juul
    Iversen, Trine Zeeberg
    Schmidt, Henrik
    Fode, Kirsten
    Svane, Inge Marie
    ONCOIMMUNOLOGY, 2016, 5 (04):
  • [9] Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab
    Sodji, Quaovi H.
    Gutkin, Paulina M.
    Swetter, Susan M.
    Reddy, Sunil A.
    Hiniker, Susan M.
    Knox, Susan J.
    MELANOMA MANAGEMENT, 2020, 7 (01) : 7 - 16
  • [10] Major Partial Response of a Recalcitrant Metastatic Malignant Melanoma to Palliative Immunotherapy with Ipilimumab
    Kowalzick, L.
    Schilling, O.
    Schaarschmidt, E.
    Mamada, A.
    Michalski, C.
    Poennighaus, J. -M.
    AKTUELLE DERMATOLOGIE, 2012, 38 (8-9) : 323 - 325
12345